Analyst Etzer Darout works at BMO and is focused on the Healthcare sector with 95 price targets and ratings documented since 2018 spanning on 17 stocks. Previously, Etzer Darout worked at GUGGENHEIM. Analyst's average stock valuation to be materialised ratio is 37.25% with an average time for price targets to be met of 86.47 days.
Most recent stock forecast was given on MRUS, Merus N.V at 16-Mar-2023.
Etzer Darout best performing recommendations are on MGNX (MACROGENICS, INC).
The best stock recommendation documented was for MGNX (MACROGENICS, INC) at 7/12/2022. The price target of $4 was fulfilled within 1 day with a profit of $0.33 (8.99%) receiving and performance score of 89.92.
Average potential price target upside
Currently, out of the existing stock ratings of Etzer Darout - 3068 which are a Buy (64.54%), 1686 which are a Hold (35.46%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
12
$10.41 (654.72%)
18
8 months 18 days ago
0/3 (0%)
$11.42 (412.49%)
Buy
8
$6.41 (403.14%)
14
8 months 18 days ago
0/6 (0%)
$14.36 (391.34%)
Buy
25
$23.76 (1916.13%)
2 years 8 days ago
0/1 (0%)
$14.91 (147.77%)
